BDTX · Categories · Form 3

BDTX - SEC Form 3 initial insider statements

Black Diamond Therapeutics Inc. (BDTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for BDTX

• 783d
  SEC Form 3 filed by new insider Campbell Shannon

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 783d
  SEC Form 3 filed by new insider Raman Prakash

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1450d
  SEC Form 3 filed by new insider Yurasov Sergey

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1513d
  SEC Form 3: New insider Biotech Growth N V claimed ownership of 3,735,846 shares

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1519d
  SEC Form 3 filed by new insider Dixon Wendy L

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1648d
  SEC Form 3 filed by new insider Jones Erika

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1648d
  SEC Form 3: New insider Ni Fang claimed ownership of 44,026 shares

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1721d
  SEC Form 3: New insider Buck Elizabeth claimed ownership of 95,192 units of Common Stock

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1758d
  SEC Form 3 filed by Black Diamond Therapeutics, Inc.

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)
• 1959d
  SEC Form 3: Kapil Dhingra claimed ownership of 10,000 units of Common Stock

  3 - Black Diamond Therapeutics, Inc. (0001701541) (Issuer)

Other BDTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends